Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Elafin

EU orphan designation number: EU/3/07/443   
Active ingredient: Elafin
Indication: Treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Sponsor: Proteo Biotech AG
Am Kiel Kanal 44, D-24106 Kiel, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/03/2007 Centralised Orphan - Designation EMEA/OD/088/06 (2007)1326 of 20/03/2007